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INTRODUCTION
Obesity and insulin resistance are related features of the Metabolic Syndrome, a cluster of medical disorders that increase the risk of developing type 2 diabetes and cardiovascular disease [1] . Increased insulin secretion by the pancreatic beta cells may compensate insulin resistance of skeletal muscle and the liver initially, but the obese state often also provokes beta cell dysfunction [2] , which largely accounts for the persistently high blood glucose level that characterises type 2 diabetes [3] . The molecular mechanisms that link obesity to insulin resistance are yet to be established conclusively but likely involve excess dietary nutrients, peptide hormones and inflammatory molecules [4] . Non-esterified fatty acids (NEFAs 1 ) are for example relatively abundant in the circulation of obese subjects [5] , and exposure of skeletal muscle and myocytes to free fatty acids -saturated long-chain species such as palmitate and stearate in particular -causes insulin resistance [6] .
The mechanism by which free fatty acids dampen the insulin sensitivity of skeletal muscle is not fully understood, but NEFA-induced insulin resistance has been associated firmly with mitochondrial dysfunction [7] [8] [9] . However, the causality of this association remains subject of fierce debate [10, 11] . It is highly conceivable that the oxidative capacity of muscle cells in obese subjects is insufficient to burn the elevated NEFA supply effectively [7, 12] and thus causes accumulation of metabolites that blunt insulin responsiveness. Molecules suggested to interfere with insulin signalling include lipid species such as ceramide and diacylglycerol [13, 14] , and mitochondrial reactive oxygen species (ROS) [15] [16] [17] . Despite experimental evidence in its favour [10] , the "mitochondrial insufficiency" model does not enjoy unanimous support [8, 11] . Various rodent models of severe mitochondrial dysfunction for example exhibit improved rather than impaired muscle insulin sensitivity [18] [19] [20] , and fat oxidation capacity tends to be increased, not decreased, in obese/insulin-resistant and type 2 diabetic subjects [11] . Moreover, type 2 diabetic patients increase their substrate oxidation rate some 40-fold in response to exercise [11] . Based on this sizeable response, it has been reasoned [11] that obese subjects should have enough spare respiratory capacity to fully oxidise any excess lipid.
The capacity of a biological system to burn metabolic fuel depends on the way it controls its energy metabolism. Arguably the most important parameter in cellular bioenergetics is the 1 Abbreviations: AHA, L-azidohomoalanin; 2DG, 2-deoxyglucose; BSA, bovine serum albumin; DMEM, Dulbecco"s modified Eagle medium; FCCP, trifluorocarbonylcyanide phenylhydrazone; FBS, fetal bovine serum; Hepes, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; KRPH, Krebs Ringer Phosphate Hepes buffer; NEFA, non-esterified fatty acid; PBS, phosphate-buffered saline; RFU, relative fluorescence units; ROS, reactive oxygen species
ATP/ADP ratio, as it is this phosphorylation potential that allow cells to perform work [21] . In muscle cells, the ATP/ADP ratio is mostly controlled by ATP demand, a paradigm [21] that is acknowledged by both proponents and opponents of the "mitochondrial insufficiency" model [10, 11] . Such distribution of control implies that the rate of ATP supply, and hence oxidative phosphorylation, is fully governed by ATP turnover. In other words, any spare respiratory capacity of a muscle cell will be inconsequential if there is no demand for ATP. Indeed, many paradoxical observations in the insulin resistance literature are readily reconciled by considering the variable energetic needs of the different experimental systems studied [8] .
As cellular energy demand clearly influences how lipids affect insulin sensitivity [8] , we deemed it important to establish whether or not NEFA exposure had any effect on the ATP requirements of skeletal muscle cells.
In this paper we report that palmitate-induced insulin resistance of rat and human skeletal muscle cells associates with a decreased rate and efficiency of oxidative phosphorylation, and, importantly, with an inhibition of major ATP-consuming processes. These data suggest that the lowered ATP supply is partly owing to decreased ATP turnover.
MATERIAL AND METHODS

Cell culture
Rat L6 myoblasts were obtained from the European Collection of Cell Culture and were maintained at 37 ºC under a humidified carbogen atmosphere in Dulbecco"s Modified Eagle
Medium (DMEM -LifeTechnology 42430-025) containing 25 mM glucose and 20 mM Hepes (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) and supplemented with 10% (v/v) FBS (fetal bovine serum), 100 U/mL penicillin, and 100 µg/mL streptomycin. Cells between passages 18 and 25 were used for experimentation. As described in detail before [22] 
allowed to double 4x before experimentation, and all assays were performed before the population had doubled 10x.
Fatty acids
Prior to NEFA exposure, cells were nutrient-restricted for 10 or 24 h (glucose uptake and cellular bioenergetics assays, respectively) in DMEM (Life Technology 22320-22) containing just 5 mM glucose and supplemented with only 2% (v/v) FBS to sensitise the cells to insulin [22, 23] . NEFAs were administered in conjugation to fatty-acid-free bovine serum albumin (BSA -Sigma A7030) as described previously [22] , and cells were exposed to BSA- 
Insulin resistance
Insulin sensitivity was measured as the response of 2-deoxyglucose (2DG) uptake to 100 nM insulin as described previously [22] . The estimated free palmitate concentration of 20 nM rendered both L6 and human myoblasts insensitive to insulin following 16-h exposure ( Fig.   2B ) but did not cause significant cell loss (not shown).
Protein synthesis
The rate of de novo protein synthesis was determined by tagging newly synthesised proteins with L-azidohomoalanine (Click-iT® AHA, Invitrogen C10102) as published by others [25] . In 
Oxygen consumption
Mitochondrial respiratory activity was measured in attached cells as described before [26] .
Briefly, L6 myoblasts seeded at 4 x 10 4 cells per well and exposed to palmitate on XF24 tissue culture plates (Seahorse Bioscience) were washed 4x with a Krebs Ringer Phospate
Hepes buffer (KRPH) comprising 136 mM NaCl, 3.7 mM KCl, 10 mM Hepes, (pH 7.4), 2 mM NaH 2 PO 4 , 1 mM MgCl 2 , 1.5 mM CaCl 2 , and 0.1% (w/v) BSA, and were then incubated in this buffer for 1 h at 37 º C under air. Human myoblasts were treated similarly, but were seeded at 2-3 x 10 4 cells per well, and were not washed into KRPH, but into serum-free DMEM containing 2 mM glucose and 10 mM Hepes. Subsequently, the plates were transferred to a Seahorse XF24 extracellular flux analyser (controlled at 37 ˚C) for a 10-min calibration after which cellular oxygen consumption was recorded under various conditions to determine both ATP supply and ATP demand ( Fig. 1 ).
Fig. 1 -Skeletal muscle bioenergetics.
The ATP/ADP ratio in skeletal muscle cells is controlled by ATP demand: changes in ATP-consuming processes are countered by proportional changes in ATP supply. Under aerobic conditions, ATP is mainly supplied by oxidative phosphorylation. Mitochondrial substrate oxidation (measured as rotenoneand-antimycin-A-(Rot/AA)-sensitive oxygen uptake) builds a protonmotive force (pmf) across the mitochondrial inner membrane that is either used to make ATP (oligomycinsensitive oxygen uptake) or is dissipated by proton leak (oligomycin-insensitive oxygen uptake). FCCP renders membranes protonpermeable. Protein synthesis, DNA/RNA synthesis and Na + pump activity are ATPdemanding processes that account for about two-thirds of total ATP turnover in L6 and human myoblasts (Figs 6C and 6D). These processes are inhibited by cycloheximide, actinomycin D and ouabain, respectively.
ATP supply
Following Seahorse measurement of basal cellular respiration [26] , oligomycin (5 µg/mL), activity was subtracted from all other activities to calculate bioenergetic parameters concerning mitochondrial ATP supply. Cellular respiratory control was calculated as the ratio of FCCP-stimulated and oligomycin-inhibited respiratory rates [27] , and coupling efficiency of oxidative phosphorylation was defined as the oligomycin-sensitive part of mitochondrial respiration, i.e., the respiratory proportion that is used to make ATP [27] . Respiration was normalised to cell density derived from DAPI fluorescence [28] to calculate absolute oxygen uptake. Absolute oligomycin-sensitive oxygen consumption rates were converted to ATP supply rates assuming P/O ratios of 2.41 and 2.10 for glucose and palmitate oxidation, respectively [29] .
ATP demand
In systems where the ATP/ADP ratio is fully controlled by ATP demand, the activity of an ATP-demanding process may be approximated from the change in oligomycin-sensitive mitochondrial respiratory activity that is seen upon specific inhibition of that process [30, 31] .
Cycloheximide (40 µM), actinomycin D (10 µM) and ouabain (380 µM) were applied to estimate how much ATP supply flux was allocated to fuel, respectively, protein synthesis, DNA and RNA synthesis, and sodium pump (Na + /K + -ATPase) activity (Fig. 1) . The stated inhibitor levels were selected empirically as the lowest concentrations that exerted saturating inhibitory effects on basal mitochondrial respiration without significantly affecting the FCCPuncoupled respiration.
Statistics
Mean differences were tested for statistical significance by ANOVA, applying Fisher"s LSD multiple comparison post-hoc analysis, using SPSS v17 (IBM) and Stat Graphics Plus v5.1 (Statistical Graphics Corporation) software. and human (triangles) myoblasts in the absence (white symbols) or the presence of 100 nM insulin (black symbols) as described before [22] . The differences between insulin-exposed and control cells are statistically significant (P < 0.05) at applied 2DG levels of 600 and 1000 ng/well. Panel B: 2DG uptake was measured at 30 mg/well in the absence and presence of 100 nM insulin (white and black bars, respectively) in myoblasts exposed to palmitate (PA) or BSA as described in section 2.2. *Differs significantly (P<0.05) from the equivalent condition minus insulin. Data are means ± SEM of 3 independent experiments.
RESULTS
Palmitate lowers protein synthesis rate
To examine NEFA effects on the energy metabolism of skeletal muscle cells, myoblasts were exposed to palmitate at a dose and exposure time (Material and Methods) that caused insulin resistance (Fig. 2) . Control myoblasts respond acutely to insulin as reflected by the stimulatory effect of insulin on dose-dependent 2DG accumulation by L6 and human cells ( Fig. 2A ). This responsiveness is unaffected when cells are exposed to BSA, but is fully annulled upon exposure to BSA-conjugated palmitate (Fig. 2B ).
To explore if the insulin-numbing palmitate exposure is in any way associated with changes in skeletal muscle energy demand, we measured the rate at which L6 cells make protein, a process that represents a significant source of ATP consumption in muscle and other cells [30, 32] . (Fig. 3A) . Fluorescence of cells not exposed to AHA was below 200 RFU (not shown). Palmitate increases the median frequency of the "lowfluorescence" population from about 250 to 300 counts and decreases the median "highfluorescence" frequency from 120 to 60 counts (Fig. 3B) . Consequently, the average fluorescence intensity of palmitate-exposed cells is lower than that of control cells (Fig. 3C -12 ,500 versus 18,500 RFU), which demonstrates that palmitate has lowered the rate of de novo protein synthesis by more than 30%. 
Palmitate lowers the rate and efficiency of ATP supply
Inhibition of protein synthesis by palmitate (Fig. 3 ) is expected to change mitochondrial ATP supply, because protein synthesis is a major energy-demanding process in muscle cells [32] and because muscle energy metabolism is predominantly controlled by ATP demand [21] .
Respiratory analysis reveals that palmitate-induced insulin resistance indeed coincides with statistically significant changes in oxidative phosphorylation (Fig. 4) . Basal cellular oxygen consumption in control cells is inhibited considerably by oligomycin, subsequently stimulated by FCCP, and then almost abolished by antimycin A and rotenone (Fig. 4A) . At first glance, these typical respiratory responses are not drastically different in palmitate-exposed cells, although FCCP stimulation of respiration appears attenuated in human myoblasts (Fig. 4A) .
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9 Indeed, the apparent palmitate effect on FCCP-uncoupled respiration is reflected by a decreased cell respiratory control ratio [27] in human myoblasts (Fig. 4B ). Palmitate exposure also lowers respiratory control in L6 cells, but not to a statistically significant extent (Fig. 4B ). In addition, palmitate lowers coupling efficiency of oxidative phosphorylation in human and L6 myoblasts (Fig. 4C) , i.e., it decreases the fraction of respiration that is used to make ATP. Absolute ATP synthesis flux is readily derived from oligomycin-sensitive oxygen uptake by normalising it to cell number and multiplying it by P/O. Assuming control cells are fuelled by endogenous glucose (i.e., the sole carbon source fuelling the cells during growth)
we used a P/O ratio of 2.41 [29] and calculated that rat and human myoblasts make about 150 pmol ATP per min per 40,000 cells (Fig. 4D) . Skeletal muscle suppresses glucose catabolism when lipid is available [33] , so using a P/O ratio of 2.10 [29] we established that palmitate lowers the ATP supply rate in both systems to approximately 120 pmol ATP per min per 40,000 cells (Fig. 4D) . 
Palmitate lowers ATP supply reserved for protein synthesis
A decreased rate of oxidative phosphorylation (Fig. 4) is consistent with palmitate inhibition of protein synthesis (Fig. 3) as lowering ATP supply would be a plausible myoblast response to attenuated energy demand. Indeed, inhibiting ATP turnover will acutely lower oligomycinsensitive respiratory activity of any cell that controls its energy metabolism predominantly by ATP demand [30, 31] . Figs 5A and 5B for example demonstrate that 40 µM cycloheximide causes an instant and stable decrease of basal respiration in both L6 and human myoblasts.
Oligomycin lowers respiration further and allows the cycloheximide-induced decrease to be normalised to ATP-synthesis-coupled oxygen uptake ( Fig. 5D -DMEM) . FCCP uncouples respiration from ATP synthesis and confirms that the respiratory decrease is secondary to lowered ATP demand and not to direct inhibition of mitochondrial electron transfer. At a concentration that does not affect the cell respiratory control ratio (Fig. 5C ), cycloheximide lowers oligomycin-sensitive respiration by about 35% (Fig. 5D ), which indicates that L6 and human cells use one-third of their total ATP supply to drive protein synthesis. BSA tends to lower cycloheximide sensitivity marginally, but palmitate decreases it significantly to ~ 20% of total respiration linked to ATP synthesis (Fig. 5D) . Consistent with measurement of newly made protein (Fig. 3C) , palmitate lowers ATP supply reserved for protein synthesis (Fig. 5D ).
In a separate set of experiments we also exposed L6 myoblasts to stearate, a saturated fatty acid 2 carbon atoms longer than palmitate, and to oleate and linoleate, the monounsaturated and polyunsaturated counterparts of stearate, respectively. Probably owing to different cell passage number and subtle differences in experimental conditions, coupling efficiency ( Fig.   6A ) and absolute rate of oxidative phosphorylation (Fig. 6B ) in BSA-exposed myoblasts were a little higher than those observed before ( Figs 4C and 4D+7D, respectively) . Reassuringly, however, these independent results confirm that palmitate significantly lowers the efficiency (Fig. 6A ) and the rate (Fig. 6B ) of mitochondrial ATP synthesis. Stearate has the same effect on these parameters as palmitate ( Figs 6A and 6B ). Oleate and linoleate, on the other hand, only tend to lower the ATP synthesis rate (Fig. 6B ) and have not effect on coupling efficiency (Fig. 6A ). Stearate and linoleate significantly lower cycloheximide sensitivity of mitochondrial respiration linked to ATP synthesis, but less so than palmitate (Fig. 6C) . The small negative effect of oleate on cycloheximide sensitivity is not statistically significant. All NEFAs lower the absolute ATP supply flux reserved for protein synthesis (calculated by multiplying the cycloheximide-sensitive respiration by P/O -see section 3.2), although the effects of oleate and linoleate do not reach statistical significance. 
Palmitate causes reallocation of ATP supply
The close agreement between direct (Fig. 3) and indirect (Fig. 5 ) measurement of palmitate inhibition of myoblast protein synthesis strongly supports the notion that ATP turnover rates can be derived accurately from mitochondrial respiratory analysis [30, 31] . Therefore, we also measured ATP supply used for DNA/RNA synthesis and sodium pump activity by quantifying drops in oxygen uptake seen after inhibition of these ATP-consuming processes with 10 µM actinomycin D and 380 µM ouabain, respectively. Similar to cycloheximide, actinomycin D and ouabain inhibit oligomycin-sensitive oxygen uptake without significant effect on FCCPuncoupled respiration (not shown). Normalising inhibitor-sensitive respiration to cell number and multiplying it by P/O (cf. section 3.2) yields the absolute ATP supply flux allocated to the
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12 respective processes (Fig. 7) . On average, rat myoblasts use 47, 31 and 26 pmol ATP per min per 40,000 cells to, respectively, fuel protein synthesis, sodium pump activity and DNA/RNA synthesis (Fig. 7A) . ATP supply reserved by human cells for protein and DNA/RNA synthesis is similar to that allocated by their rat counterparts, but human myoblasts use comparably little ATP (18 pmol per min per 40,000 cells) to drive the sodium pump (Fig. 7B) . Given a total ATP supply of 150 pmol ATP per min per 40,000 cells in this set of experiments (Fig. 4D) , it transpires that ~ 70% and 60% of this supply is used by rat and human cells, respectively, to fuel the sum of protein synthesis, DNA/RNA synthesis and sodium pump activity ( Figs 7C and 7D) ; the remaining 30-40% drives processes we have not assessed and thus remains unaccounted. Palmitate significantly lowers ATP supply for protein synthesis, to about 28 and 24 pmol per min per 40,000 cells in rat and human muscle myoblasts, respectively (Fig. 7) . The palmitate effect on absolute ATP supply is a little more pronounced (40-50% inhibition) than its effect on the cycloheximide sensitivity of mitochondrial respiration (Fig. 5D -33% inhibition) , which is owing to the different P/O ratios we used for palmitate-exposed and control cells (section 3.1). Palmitate lowers ATP supply for sodium pump activity by 60-70% and for human (but not rat) DNA/RNA synthesis by almost three-quarters (Fig. 7B) . Since the palmitate effect on total ATP supply is lower than its cumulative effect on ATP turnover, palmitate increases the percentage of unaccounted ATP supply in rat (Fig. 7C) and human (Fig. 7D) myoblasts.
DISCUSSION
The results reported in this paper reveal that palmitate alters mitochondrial ATP supply and ATP expenditure in rat and human myoblasts (Fig. 8 ). The data demonstrate that palmitate lowers both the rate and efficiency of ATP supply in these cells (Figs 4 and 6 ) and, importantly, changes how this supply is allocated between ATP-consuming processes (Fig.   7 ). Our finding that palmitate and other NEFAs (Fig. 6 ) remodel ATP turnover is relevant for the causality debate as to mitochondrial involvement in obesity-related insulin resistance. 
Measurement of ATP demand
ATP turnover measurement from decreases in oligomycin-sensitive respiration provoked by inhibition of ATP-consuming processes ( [30, 31] , Fig. 5 ) requires careful experimental design.
Comparison between direct and indirect protein synthesis measurement for example reveals that ATP supply allocated to this process may readily be overestimated when derived from cycloheximide-sensitive respiration [34] . Overestimation depends on cycloheximide level [34] and thus likely emerges from nonspecific inhibition of fuel oxidation. Such off-site catabolic effects of ATP demand inhibitors are expected to decrease respiration even when oxygen uptake is uncoupled from ATP synthesis with FCCP, so they would lower cell respiratory control ratios. At the concentrations we applied, cycloheximide, actinomycin D and ouabain did not lower cellular respiratory control, suggesting that inhibition of oligomycin-sensitive oxygen uptake by these compounds was only achieved indirectly via their effect on ATP turnover. Initial experiments indicated that these compounds indeed inhibit FCCP-uncoupled respiration when applied at higher levels (not shown). Direct amino acid incorporation measurements show that 25 µM cycloheximide suffices to inhibit protein synthesis [34] . The 40 µM used here is of the same order of magnitude and provokes an instant and relatively stable inhibition ( Figs 5A and 5B) that suggests a lack of secondary effects within the timescale of our assay. Importantly, cycloheximide sensitivity of coupled mitochondrial respiration is decreased by one-third when L6 myoblasts are exposed to palmitate (Fig. 5D), i.e., by a magnitude that is identical to the palmitate effect on the protein synthesis rate of these cells (Fig. 3C ). This close quantitative agreement between direct and indirect determination of the palmitate effect on protein synthesis strengthens our confidence in the validity of indirect ATP demand measurement.
Mechanistic considerations
Palmitate lowers coupling efficiency of oxidative phosphorylation (Figs 4C and 6A) and provokes reallocation of ATP supply (Fig. 7) by mechanisms that are presently unclear. The coupling efficiency phenotype likely results from palmitate effects on the proton conductance of phospholipid bilayers [35, 36] . Palmitate is for example known to induce transient pores in the mitochondrial inner membrane [37, 38] that will increase proton leak and thus lower the proportion of respiration linked to ATP synthesis. The palmitate effect on coupling efficiency is arguably small, but it is worth notice in this respect that our experiments were performed without serum and insulin. We have recently shown that insulin acutely improves mitochondrial function of L6 and human myoblasts by boosting their coupling efficiency of oxidative phosphorylation [22] . Such improvement is annulled in palmitate-exposed cells [22] -the deleterious effect of palmitate on coupling efficiency will therefore be likely amplified in the presence of insulin.
In human and L6 myoblasts, palmitate lowers ATP supply for protein synthesis and sodium pump activity and, in human cells, it also lowers the supply for DNA/RNA synthesis (Fig. 7) .
Broadly speaking, palmitate could affect ATP turnover in two ways. Skeletal muscle has remarkable remodelling ability that allows functional adaptation to environmental stimuli via activation of diverse signalling pathways [39] . Paths linking nutrient abundance to cell growth are influenced by lipids [40] and it is therefore possible that palmitate down-regulates various ATP-consuming processes directly. Alternatively, palmitate may provoke new ATP demand, 
Mitochondrial insufficiency debate
Despite the incomplete mechanistic understanding of the observed NEFA effects on ATP turnover, our finding that palmitate causes a dramatic reallocation of ATP supply in skeletal muscle (Fig. 7) informs the mitochondrial insufficiency debate. Our data support the slowly emerging awareness [8] that mitochondrial involvement in NEFA-induced insulin resistance cannot be evaluated in a meaningful way if metabolic control is ignored. Mitochondrial capacity per se may indeed be sufficient to cope with the lipid load in the obese state [11] , but without energy demand this capacity will be inconsequential. This effective mitochondrial insufficiency under conditions of low ATP demand will thus allow accumulation of the metabolites that are held responsible for NEFA-induced insulin resistance. We assert that the current "oxidative capacity", "redox signalling" and "mitochondrial load" models of skeletal muscle insulin resistance [8, 17] are conceptually the same: lipid metabolites such as diacylglycerol and ceramide [13, 14] , and ROS [15, 16] all, but exclusively, accumulate when mitochondrial substrate supply outweighs energetic needs and thus the effective oxidative phosphorylation capacity.
Concluding remarks
Our findings highlight that mitochondrial involvement in NEFA-induced insulin resistance of skeletal muscle is best considered in context of bioenergetic control. We have revealed new significant inhibitory effects of palmitate on energy expenditure of rat and human myoblasts.
We suggest that the palmitate-decreased rate of ATP supply by oxidative phosphorylation is partly owing to inhibited ATP turnover (Fig. 8) . In other words, a seemingly compromised oxidative capacity may have simply arisen from attenuated ATP demand. We believe it may be interesting to explore how palmitate affects skeletal muscle ATP expenditure of different patients as a variable NEFA-sensitivity of ATP turnover could be responsible for a differential propensity of these patients to develop muscle insulin resistance.
